Press release
Adeno-associated Virus Vectors in Gene Therapy Pipeline Analysis, 2024 | In-depth Insights Into the Clinical Trials, Emerging Drugs, Latest Approvals, Companies
Adeno-Associated Virus (AAV) Vectors in the Gene Therapy Market
" [https://www.delveinsight.com/report-store/adeno-associated-virus-aav-vectors-in-gene-therapy-pipeline-insight?utm_source=blog&utm_medium=promotion&utm_campaign=kpr]" report by DelveInsight outlines a comprehensive assessment of the present clinical/non-clinical development activities and growth prospects across the Adeno-Associated Virus (AAV) Vectors in the Gene Therapy Market.
The Adeno-Associated Virus (AAV) Vectors in Gene Therapy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers, acquisition, funding, designations, and other product-related details.
Adeno-Associated Virus (AAV) Vectors in Gene Therapy Pipeline Analysis
The report provides insights into:
*
The report provides detailed insights into the emerging therapies for the treatment of Adeno-Associated Virus (AAV) Vectors in Gene Therapy and the aggregate therapies developed by major pharma companies.
*
It accesses the different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of clinical development.
*
It outlines the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
*
The report evaluates the drugs that are under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
*
It navigates the major collaborations (company-company collaborations and company-academia collaborations), licensing agreements, financing details, data presentation by the pharma giants, and regulatory approval in the Adeno-Associated Virus (AAV) Vectors in Gene Therapy market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Learn How the Ongoing Clinical & Commercial Activities will Affect the Adeno-Associated Virus (AAV) Vectors in Gene Therapy Therapeutic Segment @ [https://www.delveinsight.com/report-store/adeno-associated-virus-aav-vectors-in-gene-therapy-pipeline-insight?utm_source=blog&utm_medium=promotion&utm_campaign=kpr]
Adeno-Associated Virus (AAV) Vectors in Gene Therapy Therapeutics Landscape
There are approx. 70+ key companies which are developing therapies for AAV vectors in gene therapy. Currently, BioMarin Pharmaceutical is leading the therapeutics market with its AAV vectors in gene therapy drug candidates in the most advanced stage of clinical development.
The Leading Companies in the Adeno-Associated Virus (AAV) Vectors in Gene Therapy Market Include:
4D Molecular therapeutics, Abeona Therapeutics, Adrenas Therapeutics, Adverum Biotechnologies, Alcyone Lifesciences, Amicus Therapeutics, Applied Genetic Technologies, Aruvant Sciences, AskBio/Selecta Biosciences, Asklepios BioPharmaceutical, Aspa therapeutics, Astellas Gene Therapies, Astellas Pharma, Atsena Therapeutics, Audentes therapeutics, AvantiBio, Axovia Therapeutics, Bayer, Biogen, BioMarin Pharmaceutical, Brain Neurotherapy Bio, Inc., BridgeBio Pharma, Capsida Biotherapeutics, Coave therapeutics, Cyprium Therapeutics, DiNAQOR, Eli lilly and company, ESTEVE, Forge Biologics, Freeline therapeutics, Gene Therapy Research Institution Co., Ltd., Gensight Biologics, Gyroscope Therapeutics, Homology medicines, Intas Pharmaceuticals, Jaguar Gene Therapy, LLC, Kriya therapeutics, Lexeo Therapeutics, Libella Gene Therapeutics, LogicBio therapeutics, LYSOGENE, MeiraGTx, Nanoscope Therapeutics, Neurogene, Neurophth, Neurophth Therapeutics, Novartis/ Arctos medical, Novartis/Vedere Bio, Ocugen, Oyster Point pharmaceuticals, Passage Bio, Pfizer, Poseida Therapeutics, Prevail therapeutics, PTC therapeutics, REGENXBIO Inc., Rocket Pharmaceuticals, Sangamo therapeuics, Sanofi/ Sirion therapeutics, Sarepta Therapeutics, Scout Bio therapeutics, Sio Gene Therapies, Solid Biosciences, Spark therapeuics (Roche), StrideBio, Takeda, Taysha Gene Therapies, Tenaya Therapeutics, Ultragenyx Pharmaceutical, uniQure, ViGeneron, Vivet Therapeutics, Voyager Therapeutics, and others.
Adeno-Associated Virus (AAV) Vectors in Gene Therapy Covered in the Report Include:
*
GS010: Gensight Biologics
*
Valoctocogene roxaparvovec: BioMarin Pharmaceutical
*
DTX401: Ultragenyx Pharmaceutical
*
AAV5-RPGR: MeiraGTx
*
Timrepigene emparvovec: Biogen
*
AMT 061: UniQure
*
RGX-314: REGENXBIO
*
SPK-8011: Spark Therapeutics
*
NFS-01: Neurophth
*
GT 005: Gyroscope Therapeutics
And Many Others
Request the Sample PDF to Get a Better Understanding of the Emerging Drugs and Key Companies @ [https://www.delveinsight.com/sample-request/adeno-associated-virus-aav-vectors-in-gene-therapy-pipeline-insight?utm_source=blog&utm_medium=promotion&utm_campaign=kpr]
Table of Contents
1. Report Introduction
2. Executive Summary
3. Adeno-Associated Virus (AAV) Vectors in Gene Therapy Current Treatment Patterns
4. Adeno-Associated Virus (AAV) Vectors in Gene Therapy - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Adeno-Associated Virus (AAV) Vectors in Gene Therapy Late Stage Products (Phase-III)
7. Adeno-Associated Virus (AAV) Vectors in Gene Therapy Mid-Stage Products (Phase-II)
8. Adeno-Associated Virus (AAV) Vectors in Gene Therapy Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Adeno-Associated Virus (AAV) Vectors in Gene Therapy Discontinued Products
13. Adeno-Associated Virus (AAV) Vectors in Gene Therapy Product Profiles
14. Key Companies in the Adeno-Associated Virus (AAV) Vectors in Gene Therapy Market
15. Key Products in the Adeno-Associated Virus (AAV) Vectors in Gene Therapy Therapeutics Segment
16. Dormant and Discontinued Products
17. Adeno-Associated Virus (AAV) Vectors in Gene Therapy Unmet Needs
18. Adeno-Associated Virus (AAV) Vectors in Gene Therapy Future Perspectives
19. Adeno-Associated Virus (AAV) Vectors in Gene Therapy Analyst Review
20. Appendix
21. Report Methodology
Download Sample PDF to Explore the Key Offerings of the Report: [https://www.delveinsight.com/sample-request/adeno-associated-virus-aav-vectors-in-gene-therapy-pipeline-insight?utm_source=blog&utm_medium=promotion&utm_campaign=kpr]
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=adenoassociated-virus-vectors-in-gene-therapy-pipeline-analysis-2024-indepth-insights-into-the-clinical-trials-emerging-drugs-latest-approvals-companies]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Adeno-associated Virus Vectors in Gene Therapy Pipeline Analysis, 2024 | In-depth Insights Into the Clinical Trials, Emerging Drugs, Latest Approvals, Companies here
News-ID: 3508237 • Views: …
More Releases from ABNewswire
NVDC Renewal Streamlines U.S. Coast Guard Documentation and Vessel Sales Support …
NVDC Renewal is a third-party platform helping vessel owners across the United States navigate federal documentation requirements. Supporting thousands of clients annually, the company provides services for title management, renewals, liens, and transfers - including dedicated tools for selling a documented vessel and managing U.S. Coast Guard documentation accurately and securely.
NVDC Renewal, a trusted provider of U.S. vessel documentation services, has expanded its support for boat owners, brokers, and commercial…
NVDC Renewal Streamlines USCG Vessel Abstract of Title and COI Inspection Suppor …
NVDC Renewal is a third-party provider of U.S. vessel documentation services, assisting thousands of boaters and operators each year. The company helps clients file, renew, and manage federal documentation through the National Vessel Documentation Center. From abstracts of title to COI compliance support, NVDC Renewal delivers reliable, fast, and user-friendly solutions for the maritime community.
NVDC Renewal, a trusted provider of U.S. Coast Guard vessel documentation services, has announced expanded offerings…
National Aviation Center Helps Aircraft Owners Accelerate FAA Registration and C …
The National Aviation Center is a private service helping aircraft owners with FAA registration, renewals, transfers, and compliance filings. Though not affiliated with the FAA, it follows all regulatory standards. Known for its fast, secure, and professional support, the center is trusted by private pilots, commercial operators, and aviation professionals seeking reliable documentation assistance across the United States.
The National Aviation Center [https://nationalaviationcenter.us/], a trusted private service provider for FAA documentation,…
Marketing Expert Tony Hayes Reveals 10 AI-Powered Strategies Revolutionizing Dig …
Internet marketing veteran Tony Hayes releases a comprehensive newsletter edition exposing how ChatGPT Atlas, Claude AI, and emerging tools are disrupting traditional advertising agencies and content creation workflows. The edition includes detailed implementation checklists and 25 key takeaways per strategy, designed to help businesses stay competitive in rapidly evolving digital landscape.
Pattaya - 3 November, 2025 - Tony Hayes, veteran internet marketing strategist and YouTube content creator, has released a comprehensive…
More Releases for Gene
DNA and Gene Cloning Services Market Expands with Growing Focus on Complex Gene …
InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global DNA and Gene Cloning Services Market by Type of Service Offered (Custom Cloning, Sub-cloning, Gene Synthesis, and Others), Type of Gene (Complex Gene, Standard Gene, and Others), End-User Industry (Pharmaceutical, Academic and R&D, and Biotechnology Companies, and Others)- Market Outlook and Industry Analysis 2034"
The DNA and Gene Cloning Services Market Size is valued…
Evolving Market Trends In The CRISPR Gene Editing Industry: Innovative Gene Ther …
The CRISPR Gene Editing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected CRISPR Gene Editing Market Size During the Forecast Period?
The CRISPR gene editing market has grown exponentially in recent years. It will grow from $2.26 billion in 2024 to $2.88…
Cell and Gene Therapy Market Global Analysis By Type (Cell Therapy, Gene Therapy …
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases by…
Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma …
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with…
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In …
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks.
The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,…
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies.
In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal…
